BACKGROUND: Group A rotaviruses (RVA) are a significant cause of pediatric gastroenteritis worldwide. The New Vaccine Surveillance Network (NVSN) has conducted active surveillance for RVA at pediatric hospitals and emergency departments at 3-7 geographically diverse sites in the United States since 2006. METHODS: Over 6 consecutive years, from 2008 to 2013, 1523 samples from NVSN sites that were tested positive by a Rotaclone enzyme immunoassay were submitted to the Centers for Disease Control and Prevention for genotyping. RESULTS: In the 2009, 2010, and 2011 seasons, genotype G3P[8] was the predominant genotype throughout the network, with a 46%-84% prevalence. In the 2012 season, G12P[8] replaced G3P[8] as the most common genotype, with a 70% prevalence, and this trend persisted in 2013 (68.0% prevalence). Vaccine (RotaTeq; Rotarix) strains were detected in 0.6%-3.4% of genotyped samples each season. Uncommon and unusual strains (eg, G8P[4], G3P[24], G2P[8], G3P[4], G3P[6], G24P[14], G4P[6], and G9P[4]) were detected sporadically over the study period. Year, study site, and race were found to be significant predictors of genotype. CONCLUSIONS: Continued active surveillance is needed to monitor RVA genotypes in the United States and to detect potential changes since vaccine licensure. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Group A rotaviruses (RVA) are a significant cause of pediatric gastroenteritis worldwide. The New Vaccine Surveillance Network (NVSN) has conducted active surveillance for RVA at pediatric hospitals and emergency departments at 3-7 geographically diverse sites in the United States since 2006. METHODS: Over 6 consecutive years, from 2008 to 2013, 1523 samples from NVSN sites that were tested positive by a Rotaclone enzyme immunoassay were submitted to the Centers for Disease Control and Prevention for genotyping. RESULTS: In the 2009, 2010, and 2011 seasons, genotype G3P[8] was the predominant genotype throughout the network, with a 46%-84% prevalence. In the 2012 season, G12P[8] replaced G3P[8] as the most common genotype, with a 70% prevalence, and this trend persisted in 2013 (68.0% prevalence). Vaccine (RotaTeq; Rotarix) strains were detected in 0.6%-3.4% of genotyped samples each season. Uncommon and unusual strains (eg, G8P[4], G3P[24], G2P[8], G3P[4], G3P[6], G24P[14], G4P[6], and G9P[4]) were detected sporadically over the study period. Year, study site, and race were found to be significant predictors of genotype. CONCLUSIONS: Continued active surveillance is needed to monitor RVA genotypes in the United States and to detect potential changes since vaccine licensure. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Holly A Hill; Laurie D Elam-Evans; David Yankey; James A Singleton; Maureen Kolasa Journal: MMWR Morb Mortal Wkly Rep Date: 2015-08-28 Impact factor: 17.586
Authors: Jelle Matthijnssens; Elisabeth Heylen; Mark Zeller; Mustafizur Rahman; Philippe Lemey; Marc Van Ranst Journal: Mol Biol Evol Date: 2010-06-03 Impact factor: 16.240
Authors: Celeste M Donato; Ling Sing Ch'ng; Karen F Boniface; Nigel W Crawford; Jim P Buttery; Michael Lyon; Ruth F Bishop; Carl D Kirkwood Journal: J Infect Dis Date: 2012-05-21 Impact factor: 5.226
Authors: Geoffrey A Weinberg; Daniel C Payne; Elizabeth N Teel; Slavica Mijatovic-Rustempasic; Michael D Bowen; Mary Wikswo; Jon R Gentsch; Umesh D Parashar Journal: J Clin Microbiol Date: 2011-12-14 Impact factor: 5.948
Authors: Sarah M McDonald; Allison O McKell; Christine M Rippinger; John K McAllen; Asmik Akopov; Ewen F Kirkness; Daniel C Payne; Kathryn M Edwards; James D Chappell; John T Patton Journal: J Virol Date: 2012-06-13 Impact factor: 5.103
Authors: Daniel C Payne; Peter G Szilagyi; Mary Allen Staat; Kathryn M Edwards; Jon R Gentsch; Geoffrey A Weinberg; Caroline B Hall; Aaron T Curns; Haley Clayton; Marie R Griffin; Gerry Fairbrother; Umesh D Parashar Journal: Pediatr Infect Dis J Date: 2009-11 Impact factor: 2.129
Authors: Osbourne Quaye; Sharla McDonald; Mathew D Esona; Freda C Lyde; Slavica Mijatovic-Rustempasic; Sunando Roy; Dina J Castro Banegas; Yolanda Mencos Quiñonez; Blanca L Chinchilla; Fabián Gómez Santiago; Herlinda García Lozano; Gloria Rey-Benito; Lúcia H de Oliveira; Jon R Gentsch; Michael D Bowen Journal: Emerg Infect Dis Date: 2013-08 Impact factor: 6.883
Authors: Slavica Mijatovic-Rustempasic; Sunando Roy; Elizabeth N Teel; Geoffrey A Weinberg; Daniel C Payne; Umesh D Parashar; Michael D Bowen Journal: J Gen Virol Date: 2015-11-20 Impact factor: 3.891
Authors: Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das Journal: J Virol Date: 2018-12-10 Impact factor: 5.103
Authors: Rachel M Burke; Jacqueline E Tate; George S Han; Rebecca Quenelle; Rashi Gautam; Debra A Wadford; Michael D Bowen; Umesh D Parashar Journal: J Pediatric Infect Dis Soc Date: 2020-07-13 Impact factor: 3.164
Authors: Ran Zhuo; Gillian A M Tarr; Jianling Xie; Stephen B Freedman; Daniel C Payne; Bonita E Lee; Charlotte McWilliams; Linda Chui; Samina Ali; Xiaoli Pang Journal: J Clin Microbiol Date: 2021-08-18 Impact factor: 5.948
Authors: Aamer Imdad; Monique A Foster; Junaid Iqbal; Christopher Fonnesbeck; Daniel C Payne; Chengxian Zhang; James D Chappell; Natasha Halasa; Oscar G Gómez-Duarte Journal: Pediatr Infect Dis J Date: 2018-06 Impact factor: 2.129
Authors: Shenyuan Xu; Kristen Rose McGinnis; Yang Liu; Pengwei Huang; Ming Tan; Michael Robert Stuckert; Riley Erin Burnside; Elsa Grace Jacob; Shuisong Ni; Xi Jiang; Michael A Kennedy Journal: Proc Natl Acad Sci U S A Date: 2021-09-07 Impact factor: 11.205
Authors: Natasha Halasa; Bhinnata Piya; Laura S Stewart; Herdi Rahman; Daniel C Payne; Amy Woron; Linda Thomas; Lisha Constantine-Renna; Katie Garman; Rendie McHenry; James Chappell; Andrew J Spieker; Christopher Fonnesbeck; Einas Batarseh; Lubna Hamdan; Mary E Wikswo; Umesh Parashar; Michael D Bowen; Jan Vinjé; Aron J Hall; John R Dunn Journal: Clin Infect Dis Date: 2021-02-16 Impact factor: 9.079
Authors: Olga A Kondakova; Peter A Ivanov; Oleg A Baranov; Ekaterina M Ryabchevskaya; Marina V Arkhipenko; Eugene V Skurat; Ekaterina A Evtushenko; Nikolai A Nikitin; Olga V Karpova Journal: Clin Exp Vaccine Res Date: 2021-05-31